Smith & Nephew has finally settled “compliance” cases with US departments of Justice and Securities and Exchange Commission incurring penalties totalling $22.2M.
Smith & Nephew’s 2011 was pretty good according to its financials and the company is getting a handle on its costs, suggesting a strong 2012, albeit at the expense of further job losses.
Smith & Nephew is to form a joint venture with Essex Woodlands, a specialist healthcare growth equity and venture capital firm, to create a US-based joint venture with the goal of advancing its Biologics and Clinical Therapy solutions.
The ongoing legal dispute between Smith & Nephew and Arthrex Inc relating to patent infringement claims, has been thrown out on appeal by a US Judge.
Smith and Nephew has recently combined its Orthopaedic and Trauma Business with its Endoscopy business and has now announced 80 job losses in Memphis Orthopaedic Division.
Medtech industry body Eucomed has announced that Smith & Nephew is the second member company to be granted a licence to use the newly launched Ethical Business Logo.
Smith & Nephew results for the third quarter show revenue increase, margin decrease and $150m cost reduction plans.
Smith & Nephew has announced the appointment of Stéphane Thiroloix to the position of President, Europe Advanced Surgical Devices Division
Smith & Nephew enhances its reputation as educator with the introduction of its training simulator for Gynecologists
The Advanced Wound Management division of Smith & Nephew, has announced the launch of its VERSAJET II Hydrosurgery system for precise excision during surgical debridement.
Smith & Nephew has announced the launch of its innovative, single-use DYONICS PLATINUM Series Shaver Blades
Smith & Nephew Plc rose the most in almost eight months in London trading after four U.K. newspapers reported that traders were speculating the maker of artificial knees and hips may receive a takeover offer.
Smith & Nephew, Inc., Endoscopy Division, has announced that the company has filed a patent
infringement lawsuit in US District Court for the Eastern District of Texas against privately-held Arthrex, Inc. relating to Endobutton patents
Smith & Nephew’s Advanced Wound Management division, announce the European launch of ACTICOAT Flex 3 and ACTICOAT Flex 7, to expand the ACTICOAT portfolio.
Smith & Nephew Biologics & Spine is proceeding to the next stage in the approval process for the U.S. launch of DUROLANE® Single Injection, Stabilized Hyaluronic Acid.
Smith & Nephew’s Endoscopy Division today announced the launch of the BICEPTOR Tenodesis System to treat injuries to the biceps tendon in the shoulder.